Skip to main content
Premium Trial:

Request an Annual Quote

Waters Teams with Irish Institute on Database for Glycan Analysis

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters is working with Ireland's National Institute for Bioprocessing Research and Training (NIBRT) to create the world's first database for glycan analysis by UltraPerformance Liquid Chromatography, the partners said today.

The new database, which is expected to be available in 2011, will be developed at NIBRT and "will be a first-of-its-kind repository of chromatographic retention times for sets of glycan structures associated with a range of biotherapeutics," they said.

In addition, NIBRT will maintain and license the database, while Waters and NIBRT will co-market it worldwide.

"By combining our know-how in separations and glycan analysis with NIBRT's expertise in glycobiology we can make fast and accurate glycosylation analysis a reality for the makers of biotherapeutics," Jeff Mazzeo, director of biopharmaceutical business operations for Waters, said in a statement.

Waters sells the UPLC Glycan Analysis Solution, which includes its Acquity UPLC BEH Glycan Separation Technology column and an Acquity UPLC System with fluorescence detection.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.